SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3gp0'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1HRK_A_CHDA1501_0 (FERROCHELATASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	LEU A 285 ILE A 273 LEU A 113 PRO A 153 VAL A 156	None	1.23A	1hrkA-3gp0A: undetectable	1hrkA-3gp0A: 23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_F_THAF6_1 (LIVER CARBOXYLESTERASE I)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	VAL A 102 LEU A 55 LEU A 75 LEU A 104 LEU A 74	None None NIL A 1 ( 4.8A) NIL A 1 ( 4.3A) None	0.94A	1mx1F-3gp0A: undetectable	1mx1F-3gp0A: 22.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ALA A 51 GLU A 71 LEU A 75 THR A 106 HIS A 148	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 (-4.3A)	0.51A	1uwhA-3gp0A: 22.5	1uwhA-3gp0A: 27.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LYS A 53 GLU A 71 LEU A 75 THR A 106 HIS A 148	NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 (-4.3A)	0.67A	1uwhB-3gp0A: 22.5	1uwhB-3gp0A: 27.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENE SERINE/THREONINE-PRO TEIN KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	VAL A 38 ALA A 51 GLU A 71 THR A 106 HIS A 148	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.3A)	0.53A	1uwjA-3gp0A: 5.6	1uwjA-3gp0A: 27.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 9	VAL A 38 LEU A 86 LEU A 104 LEU A 108 MET A 109	NIL A 1 ( 4.7A) None NIL A 1 ( 4.3A) NIL A 1 ( 4.4A) None	0.63A	1xkkA-3gp0A: 20.5	1xkkA-3gp0A: 25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 9	VAL A 38 LYS A 53 LEU A 86 LEU A 104 LEU A 108	NIL A 1 ( 4.7A) None None NIL A 1 ( 4.3A) NIL A 1 ( 4.4A)	0.67A	1xkkA-3gp0A: 20.5	1xkkA-3gp0A: 25.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_A_CHDA701_0 (FERROCHELATASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	LEU A 285 ILE A 273 LEU A 113 PRO A 153 VAL A 156	None	1.23A	2hrcA-3gp0A: undetectable	2hrcA-3gp0A: 23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRC_B_CHDB1605_0 (FERROCHELATASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	LEU A 285 ILE A 273 LEU A 113 PRO A 153 VAL A 156	None	1.22A	2hrcB-3gp0A: undetectable	2hrcB-3gp0A: 23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO5_A_CHDA501_0 (FERROCHELATASE, MITOCHONDRIAL)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	LEU A 285 ILE A 273 LEU A 113 PRO A 153 VAL A 156	None	1.15A	2po5A-3gp0A: undetectable	2po5A-3gp0A: 23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PO7_B_CHDB501_0 (FERROCHELATASE, MITOCHONDRIAL)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	LEU A 285 ILE A 273 LEU A 113 PRO A 153 VAL A 156	None	1.23A	2po7B-3gp0A: undetectable	2po7B-3gp0A: 23.39
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QK8_A_MTXA200_1 (DIHYDROFOLATE REDUCTASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ALA A 190 LEU A 291 ILE A 259 LEU A 247 PRO A 244	None	1.23A	2qk8A-3gp0A: undetectable	2qk8A-3gp0A: 17.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2YZQ_A_SAMA6075_0 (PUTATIVE UNCHARACTERIZED PROTEIN PH1780)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ASP A 98 ARG A 5 THR A 91 ILE A 96 GLU A 97	None	1.31A	2yzqA-3gp0A: undetectable	2yzqA-3gp0A: 21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3A51_E_VDYE6178_1 (VITAMIN D HYDROXYLASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ILE A 96 ALA A 93 THR A 91 VAL A 345 LEU A 346	None	1.03A	3a51E-3gp0A: undetectable	3a51E-3gp0A: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ADX_A_IMNA2_2 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 7	ILE A 212 ILE A 235 LEU A 216 LEU A 270	None	0.89A	3adxA-3gp0A: undetectable	3adxA-3gp0A: 22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3B9L_A_AZZA1009_1 (SERUM ALBUMIN)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 8	TYR A 200 GLU A 192 SER A 293 HIS A 142	None	1.13A	3b9lA-3gp0A: undetectable	3b9lA-3gp0A: 20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_B_NILB600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ALA A 51 GLU A 71 THR A 106 HIS A 148 ASP A 168	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.36A	3cs9B-3gp0A: 22.5	3cs9B-3gp0A: 25.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CS9_C_NILC600_1 (PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ALA A 51 GLU A 71 THR A 106 HIS A 148 ASP A 168	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.29A	3cs9C-3gp0A: 22.3	3cs9C-3gp0A: 25.76
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	ALA A 51 GLU A 71 LEU A 75 THR A 106 ILE A 141 HIS A 148 LEU A 167 ASP A 168	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.3A) NIL A 1 (-4.0A) NIL A 1 (-4.6A)	0.79A	3gcsA-3gp0A: 40.6	3gcsA-3gp0A: 74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	ALA A 51 LEU A 74 LEU A 75 THR A 106 ILE A 141 HIS A 148 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.76A	3gcsA-3gp0A: 40.6	3gcsA-3gp0A: 74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	ALA A 51 LEU A 75 ILE A 84 THR A 106 ILE A 141 HIS A 148 LEU A 167 ASP A 168	NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.3A) NIL A 1 (-4.0A) NIL A 1 (-4.6A)	0.80A	3gcsA-3gp0A: 40.6	3gcsA-3gp0A: 74.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	VAL A 38 ALA A 51 LEU A 74 LEU A 75 THR A 106	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A)	0.61A	3gcsA-3gp0A: 40.6	3gcsA-3gp0A: 74.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3H5G_B_LEIB16_0 (COIL SER L16D-PEN)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 5	LEU A 104 LYS A 76 LEU A 72 GLU A 71	NIL A 1 ( 4.3A) None None NIL A 1 (-3.7A)	1.12A	3h5gA-3gp0A: undetectable 3h5gB-3gp0A: undetectable	3h5gA-3gp0A: 7.54 3h5gB-3gp0A: 7.54
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	9 / 12	ALA A 51 GLU A 71 LEU A 74 LEU A 75 THR A 106 LEU A 108 LEU A 167 ASP A 168 PHE A 169	NIL A 1 (-3.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 ( 4.4A) NIL A 1 (-4.0A) NIL A 1 (-4.6A) NIL A 1 (-3.5A)	0.70A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	ALA A 51 GLU A 71 LEU A 75 ILE A 84 THR A 106 LEU A 167 ASP A 168 PHE A 169	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.0A) NIL A 1 (-4.6A) NIL A 1 (-3.5A)	0.67A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LEU A 78 LEU A 75 ILE A 84 THR A 106 LEU A 167	NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.0A)	1.49A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LYS A 53 THR A 106 LEU A 108 LEU A 167 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-3.3A) NIL A 1 ( 4.4A) NIL A 1 (-4.0A) NIL A 1 (-4.6A)	0.73A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	9 / 12	VAL A 30 ALA A 51 GLU A 71 LEU A 74 LEU A 75 THR A 106 LEU A 108 ASP A 168 PHE A 169	None NIL A 1 (-3.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 ( 4.4A) NIL A 1 (-4.6A) NIL A 1 (-3.5A)	0.82A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 30 ALA A 51 LYS A 53 THR A 106 LEU A 108 ASP A 168	None NIL A 1 (-3.7A) None NIL A 1 (-3.3A) NIL A 1 ( 4.4A) NIL A 1 (-4.6A)	0.61A	3hecA-3gp0A: 41.8	3hecA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 GLU A 71 LEU A 75 THR A 106 ILE A 141 ASP A 168	NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.6A)	0.73A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LEU A 74 LEU A 75 THR A 106 ILE A 141 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.6A)	0.75A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LEU A 75 ILE A 84 THR A 106 ILE A 141 ASP A 168	NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.6A)	0.71A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LYS A 53 GLU A 71 THR A 106 ILE A 141 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-3.3A) None NIL A 1 (-4.6A)	1.06A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ALA A 51 LYS A 53 ILE A 84 THR A 106 ILE A 141 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.6A)	1.08A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 30 VAL A 38 ALA A 51 GLU A 71 LEU A 75 THR A 106	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A)	0.84A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 30 VAL A 38 ALA A 51 LEU A 74 LEU A 75 THR A 106	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A)	0.66A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 LEU A 75 THR A 106 ILE A 141	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None	0.94A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LEU A 74 LEU A 75 THR A 106 ILE A 141	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None	0.91A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LEU A 75 ILE A 84 THR A 106 ILE A 141	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None	0.95A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 6	VAL A 83 ILE A 146 HIS A 148 ILE A 166 LEU A 167	NIL A 1 (-4.9A) None NIL A 1 (-4.3A) NIL A 1 ( 4.9A) NIL A 1 (-4.0A)	0.43A	3hegA-3gp0A: 42.4	3hegA-3gp0A: 75.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IAZ_A_AINA1202_1 (LACTOTRANSFERRIN)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	GLU A 237 GLY A 240 THR A 241	None	0.46A	3iazA-3gp0A: undetectable	3iazA-3gp0A: 19.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 8	VAL A 30 ALA A 51 GLU A 71 LEU A 104 LEU A 108 MET A 109	None NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.3A) NIL A 1 ( 4.4A) None	0.72A	3lfaA-3gp0A: 40.5	3lfaA-3gp0A: 75.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 8	VAL A 30 ALA A 51 GLU A 71 LEU A 104 THR A 106 LEU A 108	None NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.3A) NIL A 1 (-3.3A) NIL A 1 ( 4.4A)	0.50A	3lfaA-3gp0A: 40.5	3lfaA-3gp0A: 75.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	GLY A 31 VAL A 38 ALA A 51 LEU A 75 ILE A 84 THR A 106 ASN A 114 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A)	1.19A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	9 / 12	GLY A 31 VAL A 38 ALA A 51 LYS A 53 LEU A 75 ILE A 84 THR A 106 ASN A 115 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A)	1.04A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	VAL A 30 GLY A 31 VAL A 38 ALA A 51 LEU A 75 THR A 106 ASN A 114 LEU A 167	None None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A)	1.15A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	VAL A 30 GLY A 31 VAL A 38 ALA A 51 LEU A 75 THR A 106 ASN A 115 LEU A 167	None None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A)	1.15A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	VAL A 38 ALA A 51 LYS A 53 ILE A 84 THR A 106 ASN A 115 LEU A 167 PHE A 169	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A) NIL A 1 (-3.5A)	1.16A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_2 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	GLU A 71 LEU A 104 LEU A 108	NIL A 1 (-3.7A) NIL A 1 ( 4.3A) NIL A 1 ( 4.4A)	0.34A	3ohtA-3gp0A: 33.1	3ohtA-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	GLY A 31 VAL A 38 ALA A 51 LEU A 75 ILE A 84 THR A 106 ASN A 114	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None	1.20A	3ohtB-3gp0A: 32.9	3ohtB-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	GLY A 31 VAL A 38 ALA A 51 LEU A 75 ILE A 84 THR A 106 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.0A)	0.73A	3ohtB-3gp0A: 32.9	3ohtB-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	8 / 12	GLY A 31 VAL A 38 ALA A 51 LYS A 53 ILE A 84 THR A 106 ASN A 115 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-4.4A) NIL A 1 (-3.3A) None NIL A 1 (-4.0A)	1.02A	3ohtB-3gp0A: 32.9	3ohtB-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_2 (P38A)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	GLU A 71 LEU A 104 LEU A 108	NIL A 1 (-3.7A) NIL A 1 ( 4.3A) NIL A 1 ( 4.4A)	0.33A	3ohtB-3gp0A: 32.9	3ohtB-3gp0A: 68.34
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RGF_A_BAXA465_1 (CYCLIN-DEPENDENT KINASE 8)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 LEU A 75 ILE A 84 HIS A 148	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-4.4A) NIL A 1 (-4.3A)	0.51A	3rgfA-3gp0A: 10.0	3rgfA-3gp0A: 30.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3RGF_A_BAXA465_2 (CYCLIN-DEPENDENT KINASE 8)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 7	LYS A 53 LEU A 78 VAL A 83 ASP A 168	None None NIL A 1 (-4.9A) NIL A 1 (-4.6A)	0.25A	3rgfA-3gp0A: 8.5	3rgfA-3gp0A: 30.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UJ6_A_SAMA300_1 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 4	SER A 293 ASP A 205 ASP A 150 ALA A 190	None	1.44A	3uj6A-3gp0A: undetectable	3uj6A-3gp0A: 20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZMD_A_SALA201_1 (PUTATIVE TRANSCRIPTIONAL REGULATOR)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 8	ARG A 73 LEU A 74 ARG A 70 GLU A 325	EDO A 351 (-3.6A) None None None	1.20A	3zmdA-3gp0A: undetectable 3zmdB-3gp0A: undetectable	3zmdA-3gp0A: 18.61 3zmdB-3gp0A: 18.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ZOS_B_0LIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	ALA A 51 LYS A 53 GLU A 71 ILE A 84 THR A 106 HIS A 148 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.74A	3zosB-3gp0A: 22.0	3zosB-3gp0A: 25.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_A_STIA1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 ILE A 84 THR A 106 ASP A 168	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.6A)	0.52A	4bkjA-3gp0A: 22.2	4bkjA-3gp0A: 25.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4BKJ_B_STIB1000_1 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 ILE A 84 THR A 106 ASP A 168	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 (-4.6A)	0.47A	4bkjB-3gp0A: 22.2	4bkjB-3gp0A: 25.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	ALA A 51 LYS A 53 GLU A 71 LEU A 75 THR A 106 HIS A 148 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.77A	4c8bA-3gp0A: 21.8	4c8bA-3gp0A: 25.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 2)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	ALA A 51 LYS A 53 GLU A 71 LEU A 75 THR A 106 HIS A 148 ASP A 168	NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A)	0.71A	4c8bB-3gp0A: 22.0	4c8bB-3gp0A: 25.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4I41_A_MIXA500_1 (SERINE/THREONINE-PRO TEIN KINASE PIM-1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	VAL A 38 ALA A 51 ILE A 84 ASP A 112 ASP A 150 LYS A 152 ASN A 155	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-4.4A) None None None None	0.71A	4i41A-3gp0A: 21.4	4i41A-3gp0A: 26.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IMA_D_ADND604_1 (PYRUVATE KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	ARG A 136 GLU A 81 ASN A 82	None	0.73A	4imaD-3gp0A: undetectable	4imaD-3gp0A: 22.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4IP7_D_ADND604_1 (PYRUVATE KINASE ISOZYMES L)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	ARG A 136 GLU A 81 ASN A 82	None	0.70A	4ip7D-3gp0A: undetectable	4ip7D-3gp0A: 22.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4QYQ_C_3CJC607_1 (LACTOPEROXIDASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 6	GLN A 202 ASP A 205 HIS A 142 ARG A 149	None	1.40A	4qyqC-3gp0A: 0.0	4qyqC-3gp0A: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4R7I_A_STIA1001_1 (MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 THR A 106 ASP A 168 PHE A 169	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.6A) NIL A 1 (-3.5A)	0.71A	4r7iA-3gp0A: 22.2	4r7iA-3gp0A: 26.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 10	ALA A 51 LYS A 53 ILE A 84 THR A 106 LEU A 108	NIL A 1 (-3.7A) None NIL A 1 (-4.4A) NIL A 1 (-3.3A) NIL A 1 ( 4.4A)	0.55A	4rz7A-3gp0A: 8.0	4rz7A-3gp0A: 15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4U0I_A_0LIA1001_2 (MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST/STEM CELL GROWTH FACTOR RECEPTOR KIT)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	ALA A 51 LYS A 53 LEU A 75 THR A 106 HIS A 148 ASP A 168 PHE A 169	NIL A 1 (-3.7A) None NIL A 1 ( 4.8A) NIL A 1 (-3.3A) NIL A 1 (-4.3A) NIL A 1 (-4.6A) NIL A 1 (-3.5A)	1.02A	4u0iA-3gp0A: 22.2	4u0iA-3gp0A: 26.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 7	VAL A 38 LYS A 53 ILE A 84 ILE A 166	NIL A 1 ( 4.7A) None NIL A 1 (-4.4A) NIL A 1 ( 4.9A)	0.33A	4uxqA-3gp0A: 22.9	4uxqA-3gp0A: 29.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5CZY_A_SAMA603_0 (LEGIONELLA EFFECTOR LEGAS4)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	GLY A 137 ARG A 136 SER A 298 TYR A 132 LEU A 151	None	1.25A	5czyA-3gp0A: undetectable	5czyA-3gp0A: 20.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5FSA_A_X2NA590_2 (CYP51 VARIANT1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	3 / 3	PRO A 58 ILE A 84 SER A 100	None NIL A 1 (-4.4A) None	0.67A	5fsaA-3gp0A: undetectable	5fsaA-3gp0A: 20.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5H2U_A_1N1A501_1 (PROTEIN-TYROSINE KINASE 6)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	ARG A 28 VAL A 38 ALA A 51 THR A 106 LEU A 108 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 ( 4.4A) NIL A 1 (-4.0A)	1.12A	5h2uA-3gp0A: 20.5	5h2uA-3gp0A: 26.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HPW_C_3CJC609_1 (LACTOPEROXIDASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	4 / 6	GLN A 202 ASP A 205 HIS A 142 ARG A 149	None	1.40A	5hpwC-3gp0A: 0.0	5hpwC-3gp0A: 21.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_B_ADNB401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 9	GLY A 31 VAL A 38 ALA A 51 ILE A 84 MET A 109 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-4.4A) None NIL A 1 (-4.0A)	0.89A	5lw1B-3gp0A: 37.6	5lw1B-3gp0A: 14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 10	GLY A 31 VAL A 38 ALA A 51 ILE A 84 LEU A 108 MET A 109 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-4.4A) NIL A 1 ( 4.4A) None NIL A 1 (-4.0A)	0.83A	5lw1E-3gp0A: 37.2	5lw1E-3gp0A: 14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 9	GLY A 31 VAL A 38 ALA A 51 LEU A 108 MET A 109 LEU A 167	None NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.4A) None NIL A 1 (-4.0A)	0.79A	5lw1H-3gp0A: 37.5	5lw1H-3gp0A: 14.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 GLU A 71 LEU A 104 THR A 106 GLY A 110	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) NIL A 1 (-3.7A) NIL A 1 ( 4.3A) NIL A 1 (-3.3A) None	0.73A	5vcyA-3gp0A: 22.6	5vcyA-3gp0A: 25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5VCY_A_DB8A401_1 (MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LYS A 53 GLU A 71 THR A 106 GLY A 110	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-3.3A) None	0.84A	5vcyA-3gp0A: 22.6	5vcyA-3gp0A: 25.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5XXI_A_LSNA501_1 (CYTOCHROME P450 2C9)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	5 / 12	ALA A 299 VAL A 83 VAL A 209 LEU A 74 LEU A 78	None NIL A 1 (-4.9A) None None None	1.07A	5xxiA-3gp0A: undetectable	5xxiA-3gp0A: 22.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6BSD_A_1N1A901_0 (EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	7 / 12	VAL A 38 ALA A 51 LYS A 53 GLU A 71 ILE A 84 THR A 106 MET A 109	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-4.4A) NIL A 1 (-3.3A) None	0.69A	6bsdA-3gp0A: 21.4	6bsdA-3gp0A: 12.75
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_A_STIA604_0 (TYROSINE-PROTEIN KINASE ABL1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LYS A 53 GLU A 71 THR A 106 ASP A 168	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.6A)	0.53A	6hd4A-3gp0A: 21.9	6hd4A-3gp0A: 13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD4_B_STIB602_0 (TYROSINE-PROTEIN KINASE ABL1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LYS A 53 GLU A 71 THR A 106 ASP A 168	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.6A)	0.58A	6hd4B-3gp0A: 21.8	6hd4B-3gp0A: 13.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6HD6_B_STIB601_0 (TYROSINE-PROTEIN KINASE ABL1)	3gp0	MITOGEN-ACTIVATED PROTEIN KINASE 11 (Homo sapiens)	6 / 12	VAL A 38 ALA A 51 LYS A 53 GLU A 71 THR A 106 ASP A 168	NIL A 1 ( 4.7A) NIL A 1 (-3.7A) None NIL A 1 (-3.7A) NIL A 1 (-3.3A) NIL A 1 (-4.6A)	0.53A	6hd6B-3gp0A: 21.8	6hd6B-3gp0A: 13.26

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1HRK_A_CHDA1501_0","FERROCHELATASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"LEU A 285;ILE A 273;LEU A 113;PRO A 153;VAL A 156","None","1.23A","1hrkA-3gp0A:undetectable","1hrkA-3gp0A:23.39"],["1MX1_F_THAF6_1","LIVER CARBOXYLESTERASE I","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A 102;LEU A  55;LEU A  75;LEU A 104;LEU A  74","None;None;NIL A   1 ( 4.8A);NIL A   1 ( 4.3A);None","0.94A","1mx1F-3gp0A:undetectable","1mx1F-3gp0A:22.08"],["1UWH_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A  51;GLU A  71;LEU A  75;THR A 106;HIS A 148","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 (-4.3A)","0.51A","1uwhA-3gp0A:22.5","1uwhA-3gp0A:27.68"],["1UWH_B_BAXB1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LYS A  53;GLU A  71;LEU A  75;THR A 106;HIS A 148","NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 (-4.3A)","0.67A","1uwhB-3gp0A:22.5","1uwhB-3gp0A:27.68"],["1UWJ_A_BAXA1723_1","B-RAF PROTO-ONCOGENE SERINE\/THREONINE-PROTEIN KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A  38;ALA A  51;GLU A  71;THR A 106;HIS A 148","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.3A)","0.53A","1uwjA-3gp0A:5.6","1uwjA-3gp0A:27.68"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A  38;LEU A  86;LEU A 104;LEU A 108;MET A 109","NIL A   1 ( 4.7A);None;NIL A   1 ( 4.3A);NIL A   1 ( 4.4A);None","0.63A","1xkkA-3gp0A:20.5","1xkkA-3gp0A:25.95"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A  38;LYS A  53;LEU A  86;LEU A 104;LEU A 108","NIL A   1 ( 4.7A);None;None;NIL A   1 ( 4.3A);NIL A   1 ( 4.4A)","0.67A","1xkkA-3gp0A:20.5","1xkkA-3gp0A:25.95"],["2HRC_A_CHDA701_0","FERROCHELATASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"LEU A 285;ILE A 273;LEU A 113;PRO A 153;VAL A 156","None","1.23A","2hrcA-3gp0A:undetectable","2hrcA-3gp0A:23.39"],["2HRC_B_CHDB1605_0","FERROCHELATASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"LEU A 285;ILE A 273;LEU A 113;PRO A 153;VAL A 156","None","1.22A","2hrcB-3gp0A:undetectable","2hrcB-3gp0A:23.39"],["2PO5_A_CHDA501_0","FERROCHELATASE, MITOCHONDRIAL","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"LEU A 285;ILE A 273;LEU A 113;PRO A 153;VAL A 156","None","1.15A","2po5A-3gp0A:undetectable","2po5A-3gp0A:23.39"],["2PO7_B_CHDB501_0","FERROCHELATASE, MITOCHONDRIAL","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"LEU A 285;ILE A 273;LEU A 113;PRO A 153;VAL A 156","None","1.23A","2po7B-3gp0A:undetectable","2po7B-3gp0A:23.39"],["2QK8_A_MTXA200_1","DIHYDROFOLATE REDUCTASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A 190;LEU A 291;ILE A 259;LEU A 247;PRO A 244","None","1.23A","2qk8A-3gp0A:undetectable","2qk8A-3gp0A:17.82"],["2YZQ_A_SAMA6075_0","PUTATIVE UNCHARACTERIZED PROTEIN PH1780","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ASP A  98;ARG A   5;THR A  91;ILE A  96;GLU A  97","None","1.31A","2yzqA-3gp0A:undetectable","2yzqA-3gp0A:21.59"],["3A51_E_VDYE6178_1","VITAMIN D HYDROXYLASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ILE A  96;ALA A  93;THR A  91;VAL A 345;LEU A 346","None","1.03A","3a51E-3gp0A:undetectable","3a51E-3gp0A:21.40"],["3ADX_A_IMNA2_2","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"ILE A 212;ILE A 235;LEU A 216;LEU A 270","None","0.89A","3adxA-3gp0A:undetectable","3adxA-3gp0A:22.58"],["3B9L_A_AZZA1009_1","SERUM ALBUMIN","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"TYR A 200;GLU A 192;SER A 293;HIS A 142","None","1.13A","3b9lA-3gp0A:undetectable","3b9lA-3gp0A:20.85"],["3CS9_B_NILB600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A  51;GLU A  71;THR A 106;HIS A 148;ASP A 168","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.36A","3cs9B-3gp0A:22.5","3cs9B-3gp0A:25.76"],["3CS9_C_NILC600_1","PROTO-ONCOGENE TYROSINE-PROTEIN KINASE ABL1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A  51;GLU A  71;THR A 106;HIS A 148;ASP A 168","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.29A","3cs9C-3gp0A:22.3","3cs9C-3gp0A:25.76"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"ALA A  51;GLU A  71;LEU A  75;THR A 106;ILE A 141;HIS A 148;LEU A 167;ASP A 168","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.3A);NIL A   1 (-4.0A);NIL A   1 (-4.6A)","0.79A","3gcsA-3gp0A:40.6","3gcsA-3gp0A:74.50"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"ALA A  51;LEU A  74;LEU A  75;THR A 106;ILE A 141;HIS A 148;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.76A","3gcsA-3gp0A:40.6","3gcsA-3gp0A:74.50"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"ALA A  51;LEU A  75;ILE A  84;THR A 106;ILE A 141;HIS A 148;LEU A 167;ASP A 168","NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.3A);NIL A   1 (-4.0A);NIL A   1 (-4.6A)","0.80A","3gcsA-3gp0A:40.6","3gcsA-3gp0A:74.50"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A  38;ALA A  51;LEU A  74;LEU A  75;THR A 106","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A)","0.61A","3gcsA-3gp0A:40.6","3gcsA-3gp0A:74.50"],["3H5G_B_LEIB16_0","COIL SER L16D-PEN","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"LEU A 104;LYS A  76;LEU A  72;GLU A  71","NIL A   1 ( 4.3A);None;None;NIL A   1 (-3.7A)","1.12A","3h5gA-3gp0A:undetectable;3h5gB-3gp0A:undetectable","3h5gA-3gp0A:7.54;3h5gB-3gp0A:7.54"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",9,"ALA A  51;GLU A  71;LEU A  74;LEU A  75;THR A 106;LEU A 108;LEU A 167;ASP A 168;PHE A 169","NIL A   1 (-3.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 ( 4.4A);NIL A   1 (-4.0A);NIL A   1 (-4.6A);NIL A   1 (-3.5A)","0.70A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"ALA A  51;GLU A  71;LEU A  75;ILE A  84;THR A 106;LEU A 167;ASP A 168;PHE A 169","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.0A);NIL A   1 (-4.6A);NIL A   1 (-3.5A)","0.67A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LEU A  78;LEU A  75;ILE A  84;THR A 106;LEU A 167","NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.0A)","1.49A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LYS A  53;THR A 106;LEU A 108;LEU A 167;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-3.3A);NIL A   1 ( 4.4A);NIL A   1 (-4.0A);NIL A   1 (-4.6A)","0.73A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",9,"VAL A  30;ALA A  51;GLU A  71;LEU A  74;LEU A  75;THR A 106;LEU A 108;ASP A 168;PHE A 169","None;NIL A   1 (-3.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 ( 4.4A);NIL A   1 (-4.6A);NIL A   1 (-3.5A)","0.82A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  30;ALA A  51;LYS A  53;THR A 106;LEU A 108;ASP A 168","None;NIL A   1 (-3.7A);None;NIL A   1 (-3.3A);NIL A   1 ( 4.4A);NIL A   1 (-4.6A)","0.61A","3hecA-3gp0A:41.8","3hecA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;GLU A  71;LEU A  75;THR A 106;ILE A 141;ASP A 168","NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.6A)","0.73A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LEU A  74;LEU A  75;THR A 106;ILE A 141;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.6A)","0.75A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LEU A  75;ILE A  84;THR A 106;ILE A 141;ASP A 168","NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.6A)","0.71A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LYS A  53;GLU A  71;THR A 106;ILE A 141;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-3.3A);None;NIL A   1 (-4.6A)","1.06A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ALA A  51;LYS A  53;ILE A  84;THR A 106;ILE A 141;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.6A)","1.08A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  30;VAL A  38;ALA A  51;GLU A  71;LEU A  75;THR A 106","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A)","0.84A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  30;VAL A  38;ALA A  51;LEU A  74;LEU A  75;THR A 106","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A)","0.66A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;LEU A  75;THR A 106;ILE A 141","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None","0.94A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LEU A  74;LEU A  75;THR A 106;ILE A 141","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None","0.91A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LEU A  75;ILE A  84;THR A 106;ILE A 141","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None","0.95A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3HEG_A_BAXA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"VAL A  83;ILE A 146;HIS A 148;ILE A 166;LEU A 167","NIL A   1 (-4.9A);None;NIL A   1 (-4.3A);NIL A   1 ( 4.9A);NIL A   1 (-4.0A)","0.43A","3hegA-3gp0A:42.4","3hegA-3gp0A:75.72"],["3IAZ_A_AINA1202_1","LACTOTRANSFERRIN","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"GLU A 237;GLY A 240;THR A 241","None","0.46A","3iazA-3gp0A:undetectable","3iazA-3gp0A:19.41"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  30;ALA A  51;GLU A  71;LEU A 104;LEU A 108;MET A 109","None;NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.3A);NIL A   1 ( 4.4A);None","0.72A","3lfaA-3gp0A:40.5","3lfaA-3gp0A:75.36"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  30;ALA A  51;GLU A  71;LEU A 104;THR A 106;LEU A 108","None;NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.3A);NIL A   1 (-3.3A);NIL A   1 ( 4.4A)","0.50A","3lfaA-3gp0A:40.5","3lfaA-3gp0A:75.36"],["3OHT_A_1N1A1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"GLY A  31;VAL A  38;ALA A  51;LEU A  75;ILE A  84;THR A 106;ASN A 114;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A)","1.19A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_A_1N1A1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",9,"GLY A  31;VAL A  38;ALA A  51;LYS A  53;LEU A  75;ILE A  84;THR A 106;ASN A 115;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A)","1.04A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_A_1N1A1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"VAL A  30;GLY A  31;VAL A  38;ALA A  51;LEU A  75;THR A 106;ASN A 114;LEU A 167","None;None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A)","1.15A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_A_1N1A1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"VAL A  30;GLY A  31;VAL A  38;ALA A  51;LEU A  75;THR A 106;ASN A 115;LEU A 167","None;None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A)","1.15A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_A_1N1A1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"VAL A  38;ALA A  51;LYS A  53;ILE A  84;THR A 106;ASN A 115;LEU A 167;PHE A 169","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A);NIL A   1 (-3.5A)","1.16A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_A_1N1A1000_2","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"GLU A  71;LEU A 104;LEU A 108","NIL A   1 (-3.7A);NIL A   1 ( 4.3A);NIL A   1 ( 4.4A)","0.34A","3ohtA-3gp0A:33.1","3ohtA-3gp0A:68.34"],["3OHT_B_1N1B1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"GLY A  31;VAL A  38;ALA A  51;LEU A  75;ILE A  84;THR A 106;ASN A 114","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None","1.20A","3ohtB-3gp0A:32.9","3ohtB-3gp0A:68.34"],["3OHT_B_1N1B1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"GLY A  31;VAL A  38;ALA A  51;LEU A  75;ILE A  84;THR A 106;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.0A)","0.73A","3ohtB-3gp0A:32.9","3ohtB-3gp0A:68.34"],["3OHT_B_1N1B1000_1","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",8,"GLY A  31;VAL A  38;ALA A  51;LYS A  53;ILE A  84;THR A 106;ASN A 115;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-4.4A);NIL A   1 (-3.3A);None;NIL A   1 (-4.0A)","1.02A","3ohtB-3gp0A:32.9","3ohtB-3gp0A:68.34"],["3OHT_B_1N1B1000_2","P38A","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"GLU A  71;LEU A 104;LEU A 108","NIL A   1 (-3.7A);NIL A   1 ( 4.3A);NIL A   1 ( 4.4A)","0.33A","3ohtB-3gp0A:32.9","3ohtB-3gp0A:68.34"],["3RGF_A_BAXA465_1","CYCLIN-DEPENDENT KINASE 8","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;LEU A  75;ILE A  84;HIS A 148","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-4.4A);NIL A   1 (-4.3A)","0.51A","3rgfA-3gp0A:10.0","3rgfA-3gp0A:30.19"],["3RGF_A_BAXA465_2","CYCLIN-DEPENDENT KINASE 8","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"LYS A  53;LEU A  78;VAL A  83;ASP A 168","None;None;NIL A   1 (-4.9A);NIL A   1 (-4.6A)","0.25A","3rgfA-3gp0A:8.5","3rgfA-3gp0A:30.19"],["3UJ6_A_SAMA300_1","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"SER A 293;ASP A 205;ASP A 150;ALA A 190","None","1.44A","3uj6A-3gp0A:undetectable","3uj6A-3gp0A:20.34"],["3ZMD_A_SALA201_1","PUTATIVE TRANSCRIPTIONAL REGULATOR;PUTATIVE TRANSCRIPTIONAL REGULATOR","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"ARG A  73;LEU A  74;ARG A  70;GLU A 325","EDO A 351 (-3.6A);None;None;None","1.20A","3zmdA-3gp0A:undetectable;3zmdB-3gp0A:undetectable","3zmdA-3gp0A:18.61;3zmdB-3gp0A:18.61"],["3ZOS_B_0LIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"ALA A  51;LYS A  53;GLU A  71;ILE A  84;THR A 106;HIS A 148;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.74A","3zosB-3gp0A:22.0","3zosB-3gp0A:25.74"],["4BKJ_A_STIA1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;ILE A  84;THR A 106;ASP A 168","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.6A)","0.52A","4bkjA-3gp0A:22.2","4bkjA-3gp0A:25.74"],["4BKJ_B_STIB1000_1","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;ILE A  84;THR A 106;ASP A 168","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 (-4.6A)","0.47A","4bkjB-3gp0A:22.2","4bkjB-3gp0A:25.74"],["4C8B_A_0LIA1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"ALA A  51;LYS A  53;GLU A  71;LEU A  75;THR A 106;HIS A 148;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.77A","4c8bA-3gp0A:21.8","4c8bA-3gp0A:25.46"],["4C8B_B_0LIB1000_1","RECEPTOR-INTERACTING SERINE\/THREONINE-PROTEIN KINASE 2","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"ALA A  51;LYS A  53;GLU A  71;LEU A  75;THR A 106;HIS A 148;ASP A 168","NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A)","0.71A","4c8bB-3gp0A:22.0","4c8bB-3gp0A:25.46"],["4I41_A_MIXA500_1","SERINE\/THREONINE-PROTEIN KINASE PIM-1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"VAL A  38;ALA A  51;ILE A  84;ASP A 112;ASP A 150;LYS A 152;ASN A 155","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-4.4A);None;None;None;None","0.71A","4i41A-3gp0A:21.4","4i41A-3gp0A:26.20"],["4IMA_D_ADND604_1","PYRUVATE KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"ARG A 136;GLU A  81;ASN A  82","None","0.73A","4imaD-3gp0A:undetectable","4imaD-3gp0A:22.26"],["4IP7_D_ADND604_1","PYRUVATE KINASE ISOZYMES L","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"ARG A 136;GLU A  81;ASN A  82","None","0.70A","4ip7D-3gp0A:undetectable","4ip7D-3gp0A:22.81"],["4QYQ_C_3CJC607_1","LACTOPEROXIDASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"GLN A 202;ASP A 205;HIS A 142;ARG A 149","None","1.40A","4qyqC-3gp0A:0.0","4qyqC-3gp0A:21.22"],["4R7I_A_STIA1001_1","MACROPHAGE COLONY-STIMULATING FACTOR 1 RECEPTOR","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;THR A 106;ASP A 168;PHE A 169","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.6A);NIL A   1 (-3.5A)","0.71A","4r7iA-3gp0A:22.2","4r7iA-3gp0A:26.29"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A  51;LYS A  53;ILE A  84;THR A 106;LEU A 108","NIL A   1 (-3.7A);None;NIL A   1 (-4.4A);NIL A   1 (-3.3A);NIL A   1 ( 4.4A)","0.55A","4rz7A-3gp0A:8.0","4rz7A-3gp0A:15.30"],["4U0I_A_0LIA1001_2","MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT,MAST\/STEM CELL GROWTH FACTOR RECEPTOR KIT","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"ALA A  51;LYS A  53;LEU A  75;THR A 106;HIS A 148;ASP A 168;PHE A 169","NIL A   1 (-3.7A);None;NIL A   1 ( 4.8A);NIL A   1 (-3.3A);NIL A   1 (-4.3A);NIL A   1 (-4.6A);NIL A   1 (-3.5A)","1.02A","4u0iA-3gp0A:22.2","4u0iA-3gp0A:26.12"],["4UXQ_A_0LIA1752_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"VAL A  38;LYS A  53;ILE A  84;ILE A 166","NIL A   1 ( 4.7A);None;NIL A   1 (-4.4A);NIL A   1 ( 4.9A)","0.33A","4uxqA-3gp0A:22.9","4uxqA-3gp0A:29.19"],["5CZY_A_SAMA603_0","LEGIONELLA EFFECTOR LEGAS4","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"GLY A 137;ARG A 136;SER A 298;TYR A 132;LEU A 151","None","1.25A","5czyA-3gp0A:undetectable","5czyA-3gp0A:20.72"],["5FSA_A_X2NA590_2","CYP51 VARIANT1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",3,"PRO A  58;ILE A  84;SER A 100","None;NIL A   1 (-4.4A);None","0.67A","5fsaA-3gp0A:undetectable","5fsaA-3gp0A:20.89"],["5H2U_A_1N1A501_1","PROTEIN-TYROSINE KINASE 6","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"ARG A  28;VAL A  38;ALA A  51;THR A 106;LEU A 108;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 ( 4.4A);NIL A   1 (-4.0A)","1.12A","5h2uA-3gp0A:20.5","5h2uA-3gp0A:26.78"],["5HPW_C_3CJC609_1","LACTOPEROXIDASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",4,"GLN A 202;ASP A 205;HIS A 142;ARG A 149","None","1.40A","5hpwC-3gp0A:0.0","5hpwC-3gp0A:21.22"],["5LW1_B_ADNB401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"GLY A  31;VAL A  38;ALA A  51;ILE A  84;MET A 109;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-4.4A);None;NIL A   1 (-4.0A)","0.89A","5lw1B-3gp0A:37.6","5lw1B-3gp0A:14.49"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"GLY A  31;VAL A  38;ALA A  51;ILE A  84;LEU A 108;MET A 109;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-4.4A);NIL A   1 ( 4.4A);None;NIL A   1 (-4.0A)","0.83A","5lw1E-3gp0A:37.2","5lw1E-3gp0A:14.49"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"GLY A  31;VAL A  38;ALA A  51;LEU A 108;MET A 109;LEU A 167","None;NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.4A);None;NIL A   1 (-4.0A)","0.79A","5lw1H-3gp0A:37.5","5lw1H-3gp0A:14.49"],["5VCY_A_DB8A401_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;GLU A  71;LEU A 104;THR A 106;GLY A 110","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);NIL A   1 (-3.7A);NIL A   1 ( 4.3A);NIL A   1 (-3.3A);None","0.73A","5vcyA-3gp0A:22.6","5vcyA-3gp0A:25.07"],["5VCY_A_DB8A401_1","MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2-INHIBITORY KINASE","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LYS A  53;GLU A  71;THR A 106;GLY A 110","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-3.3A);None","0.84A","5vcyA-3gp0A:22.6","5vcyA-3gp0A:25.07"],["5XXI_A_LSNA501_1","CYTOCHROME P450 2C9","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",5,"ALA A 299;VAL A  83;VAL A 209;LEU A  74;LEU A  78","None;NIL A   1 (-4.9A);None;None;None","1.07A","5xxiA-3gp0A:undetectable","5xxiA-3gp0A:22.43"],["6BSD_A_1N1A901_0","EPITHELIAL DISCOIDIN DOMAIN-CONTAINING RECEPTOR 1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",7,"VAL A  38;ALA A  51;LYS A  53;GLU A  71;ILE A  84;THR A 106;MET A 109","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-4.4A);NIL A   1 (-3.3A);None","0.69A","6bsdA-3gp0A:21.4","6bsdA-3gp0A:12.75"],["6HD4_A_STIA604_0","TYROSINE-PROTEIN KINASE ABL1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LYS A  53;GLU A  71;THR A 106;ASP A 168","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.6A)","0.53A","6hd4A-3gp0A:21.9","6hd4A-3gp0A:13.26"],["6HD4_B_STIB602_0","TYROSINE-PROTEIN KINASE ABL1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LYS A  53;GLU A  71;THR A 106;ASP A 168","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.6A)","0.58A","6hd4B-3gp0A:21.8","6hd4B-3gp0A:13.26"],["6HD6_B_STIB601_0","TYROSINE-PROTEIN KINASE ABL1","3gp0","MITOGEN-ACTIVATED PROTEIN KINASE 11","Homo sapiens",6,"VAL A  38;ALA A  51;LYS A  53;GLU A  71;THR A 106;ASP A 168","NIL A   1 ( 4.7A);NIL A   1 (-3.7A);None;NIL A   1 (-3.7A);NIL A   1 (-3.3A);NIL A   1 (-4.6A)","0.53A","6hd6B-3gp0A:21.8","6hd6B-3gp0A:13.26"]]